PT. Kimia Farma (Persero) Tbk
4 clinical trials · Sponsor
◉ Watch PT. Kimia Farma (Persero) Tbk
| Record | Firm | Date |
|---|---|---|
| Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell) (NCT05172193) | PT. Kimia Farma (Persero) Tbk | 2021-12-31 |
| The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine (NCT05126550) | PT. Kimia Farma (Persero) Tbk | 2021-11-13 |
| Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject (NCT04988646) | PT. Kimia Farma (Persero) Tbk | 2020-02-21 |
| Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers (NCT04982874) | PT. Kimia Farma (Persero) Tbk | 2019-12-13 |
Track PT. Kimia Farma (Persero) Tbk automatically
Every clearance here is in the API, with alerts when new ones post.